Loss of cyclin‐dependent kinase inhibitors produces adipocyte hyperplasia and obesity
Open Access
- 6 October 2004
- journal article
- fj express-summaries
- Published by Wiley in The FASEB Journal
- Vol. 18 (15) , 1925-1927
- https://doi.org/10.1096/fj.04-2631fje
Abstract
Adipocyte hyperplasia is characteristic of some forms of human obesity, but the role of adipocyte number in obesity and how normal adipocyte number is established are unclear. Preadipocytes prolifera...Keywords
Funding Information
- National Institutes of Health (ES11590, AG024387, HD38085)
This publication has 33 references indexed in Scilit:
- Reversal of obesity by targeted ablation of adipose tissueNature Medicine, 2004
- Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S PhaseJournal of Biological Chemistry, 2003
- The Cyclin-dependent Kinase Inhibitors p27Kip1 and p21Cip1 Cooperate to Restrict Proliferative Life Span in Differentiating Ovarian CellsPublished by Elsevier ,2003
- Extended Longevity in Mice Lacking the Insulin Receptor in Adipose TissueScience, 2003
- Childhood obesity: public-health crisis, common sense curePublished by Elsevier ,2002
- Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27Cell, 1996
- Radiation-induced cell cycle arrest compromised by p21 deficiencyNature, 1995
- 40-YEAR FOLLOW-UP OF OVERWEIGHT CHILDRENThe Lancet, 1989
- Body fat and adipose tissue cellularity in infants: A longitudinal studyMetabolism, 1977
- Adipose tissue cellularity in human obesityClinics in Endocrinology and Metabolism, 1976